1. Market Research
  2. > Biotechnology Market Trends
  3. > Surgery Partnering 2010-2015

Surgery Partnering 2010-2015

  • May 2015
  • -
  • Currentpartnering
  • -
  • 200 pages

Summary
Surgery Partnering 2010-2015 report provides understanding and access to the surgery partnering deals and agreements entered into by the worlds leading healthcare companies

Description

Surgery Partnering 2009-2014 report provides understanding and access to the surgery partnering deals and agreements entered into by the worlds leading healthcare companies.

•Trends in surgery partnering deals
•Top surgery deals by value
•Deals listed by company A-Z, industry sector, stage of development, technology type

Surgery Partnering 2009-2014 provides understanding and access to the surgery partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of surgery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors surgery technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 500 links to online copies of actual surgery deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of surgery partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in surgery partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.

Chapter 3 provides an overview of the leading surgery deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive directory of surgery partnering deals signed and announced since 2009. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of surgery technologies and products.

Report scope

Surgery Partnering 2009-2014 is intended to provide the reader with an in-depth understanding and access to surgery trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

•Trends in surgery dealmaking in the biopharma industry since 2009
•Access to summary headline, upfront, milestone and royalty data
•The leading surgery deals by value since 2009

In Surgery Partnering 2009-2014, the available deals are listed by:

•Headline value
•Upfront payment value
•Royalty rate value
•Company A-Z
•Industry sector
•Stage of development at signing
•Deal component type
•Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


Benefits

Surgery Partnering 2009-2014 provides the reader with the following key benefits:


•In-depth understanding of surgery deal trends since 2009
•Access to summary headline, upfront, milestone and royalty data
•Comprehensive access to over 500 actual surgery deals entered into by the world’s biopharma companies since 2009
•Insight into key deal terms included in contracts, where disclosed
•Understand the key deal terms companies have agreed in deals
•Undertake due diligence to assess suitability of your proposed deal terms for partner companies


Keywords

surgery, hospital care, partnering, licensing, deals, alliances, merger and acquisition, M&A, big pharma

Table Of Contents

Surgery Partnering 2010-2015
Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in surgery partnering

2.1. Introduction
2.2. Surgery partnering over the years
2.3. Big pharma surgery dealmaking activity
2.4. Big biotech surgery dealmaking activity
2.5. Most active surgery dealmakers
2.6. Surgery partnering by deal type
2.7. Surgery partnering industry sector
2.8. Surgery partnering by stage of development
2.9. Surgery partnering by technology type
2.10. Disclosed financial deal terms for surgery
2.10.1 Surgery headline values
2.10.2 Surgery upfront payments
2.10.3 Surgery milestone payments
2.10.4 Surgery royalty rates

Chapter 3 - Leading surgery deals

3.1. Introduction
3.2. Top surgery deals by value

Chapter 4 - Dealmaking directory

4.1. Introduction
4.2. Company A-Z
4.3. By deal type
4.4. By industry sector
4.5. By stage of development
4.6. By technology type

Chapter 5 - Partnering resource center

5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking

Appendices

Appendix 1 - Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering
Order Form - Reports
Order Form - Subscription Access Products

Table of figures

Figure 1: Surgery partnering since 2009
Figure 2: Big pharma - top 50 - surgery deals 2009 to 2014
Figure 3: Big pharma surgery deal frequency - 2009 to 2014
Figure 4: Big biotech - top 50 - surgery deals 2009 to 2014
Figure 5: Big biotech surgery deal frequency - 2009 to 2014
Figure 6: Surgery dealmaking activity- 2009 to 2014
Figure 7: Surgery partnering by deal type since 2009
Figure 8: Surgery partnering by industry sector since 2009
Figure 9: Surgery partnering by stage of development since 2009
Figure 10: Surgery partnering by technology type since 2009
Figure 11: Surgery deals with a headline value
Figure 12: Surgery deals with upfront payment values
Figure 13: Surgery deals with milestone payments
Figure 14: Surgery deals with royalty rates, %
Figure 15: Top surgery deals by value since 2009
Figure 16: Online partnering resources
Figure 17: Forthcoming partnering events
Figure 18: Deal type definitions

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Global Markets for Nanocomposites, Nanoparticles, Nanoclays, and Nanotubes

Global Markets for Nanocomposites, Nanoparticles, Nanoclays, and Nanotubes

  • $ 6650
  • Industry report
  • January 2017
  • by BCC Research

Use this report to: - Analyze nanocomposites that are in commercial use or under development, associated technologies and applications. - Provide suppliers of advanced materials, entrepreneurs, investors ...

Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets

Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets

  • $ 6650
  • Industry report
  • January 2017
  • by BCC Research

Use this report to: - Assess current market dynamics and estimate future demand for sample preparation in genomics, proteomics and epigenomics. - Gain insight into existing products as well as new developments ...

Synthetic Biology: Global Markets

January 2017 $ 6650

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.